Concerning the latter, our late-stage CAF dataset was enriched in protease inhibitors, among them Serpine2 and Slpi. These protease inhibitors were shown to contribute to metastasis by promoting vascular mimicry in breast cancer [49]. Here, SLPI is linked to breast cancer.